AI-generated summary
The authors report a randomized, double-blind, placebo-controlled trial of bright light therapy in patients with mild-to-moderate first-episode stroke and insomnia. Of 112 eligible participants, 56 were randomized, and bright light therapy was associated with better sleep latency and sleep efficiency than placebo over a 2-week trial. Because the abstract reports only a small sample, the authors' conclusions about daytime sleepiness, fatigue, mood and quality of life should be read with caution.
- Participants
- 56
- Who or what was studied
- Patients with mild-to-moderate first-episode stroke and poststroke insomnia
- Limits stated in the abstract
- The abstract reports a small randomized sample (56 of 112 eligible participants) and does not state the wavelength of the light used, only its intensity of 10,000 lux.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.lww.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Bright light therapy, Insomnia, Stroke, Trial registration, Depression, Lux. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.